← Back to Search

Senior PharmAssist Program for Medication Therapy Management

N/A

Waitlist Available

Led By Eleanor McConnell, PhD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 60 or older

Lives in one of 3 targeted communities learning to implement the Senior PharmAssist^TM core services

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 13 months post-completion of learning collaborative

Awards & highlights

Study Summary

This trialaims to refine and help implement an evidence-based intervention to improve the quality of life of low income seniors. Input from key stakeholders will be used to refine and test the intervention.

Who is the study for?

This trial is for older adults aged 60 or above, enrolled or soon to be enrolled in Medicare, with incomes at or below 200% of the poverty line. Participants must live in one of three North Carolina communities learning to implement Senior PharmAssist^TM services and seek medication assistance, Medicare counseling, or referrals from participating agencies.Check my eligibility

What is being tested?

The study evaluates the scalability of Senior PharmAssist^TM (SPA), a program aimed at improving life quality for low-income seniors. It involves refining tools with stakeholder input and supporting implementation through technical assistance and collaborative learning approaches.See study design

What are the potential side effects?

Since this intervention involves community-based support rather than medical treatment, traditional side effects are not applicable. However, participants may experience changes in their access to medications and healthcare services.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 60 years old or older.

Select...

I live in a community where Senior PharmAssist^TM services are available.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 13 months post-completion of learning collaborative

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~13 months post-completion of learning collaborative

This trial's timeline: 3 weeks for screening, Varies for treatment, and 13 months post-completion of learning collaborative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of older adults seeking service who received all 4 components of Senior PharmAssist intervention

Secondary outcome measures

Proportion of older adults receiving Medicare counseling

Proportion of older adults receiving Medication Therapy Management

Proportion of older adults receiving at least one tailored community referral

+1 more

Other outcome measures

Change in Self-rated Health

Trial Design

1Treatment groups

Experimental Treatment

Group I: Communities Adopting Senior PharmAssist Implementation ToolkitExperimental Treatment1 Intervention

Three communities will commit to learning how to implement the evidence-based, multi-component intervention, Senior PharmAssistTM (SPA), designed to improve function and quality of life of older adults with limited incomes using the SPA toolkit. The toolkit, co-developed with community leaders, will help to create a community model for implementation that addresses equitable access to medications, medication management, and community supports that promote physical function and healthy aging in place.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,359 Previous Clinical Trials

3,420,249 Total Patients Enrolled

Eleanor McConnell, PhDPrincipal InvestigatorDuke University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there presently openings for participants in this clinical experiment?

"Data posted on clinicaltrials.gov alludes to that this study is not presently accepting participants, having last updated its details on October 11th 2022. Despite the inactivity of this trial, there are 16 other research projects actively recruiting patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Senior PharmAssist: Co-Design and Evaluation of a Toolkit to Promote Scalable Implementation

2022. "Senior PharmAssist: Co-Design and Evaluation of a Toolkit to Promote Scalable Implementation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05278650.